Navigation Links
WaferGen Bio-systems Reports Completion of $15 Million Private Placement Transaction
Date:10/2/2013

FREMONT, Calif., Oct. 2, 2013 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today that it has completed a private placement to accredited investors of $15,037,500 of units consisting of shares of common stock, shares of Series 1 convertible preferred stock and warrants to purchase shares of common stock.

As previously announced, at the initial closing of the offering on August 27, 2013, the Company sold $13,668,500 of units for net proceeds of approximately $12,300,000.  At a subsequent closing on September 30, 2013, the Company sold an additional $1,369,000 of units for net proceeds of approximately $1,200,000.  In the private placement, the Company issued a total of 5,893,750 shares of common stock, 646 shares of Series 1 preferred stock (with a $0.001 per share liquidation preference and convertible into a total of 1,625,000 shares of Common Stock) and 3,759,379 five-year warrants with a $2.60 exercise price.  For additional details regarding the private placement, please see the current report on Form 8-K filed by the Company on August 28, 2013.

National Securities Corporation acted as sole placement agent in connection with the Offering and received compensation of approximately $1,300,000 cash and warrants to purchase 35.88 units at an initial exercise price of $50,000 per unit.

As previously reported, immediately prior to the initial closing of the private placement, the Company completed a restructuring transaction pursuant to which the Company exchanged shares of Series A-1 preferred stock with a liquidation preference of approximately $17.1 million, convertible notes with a principal amount of approximately $17.1 million and warrants exercisable for 565,180 shares of common stock for 2,987 shares of Series 1 preferred stock (with a $0.001 per share liquidation preference and convertible into a total of 7,513,372 shares of Common Stock), 1,067,317 shares of common sto
'/>"/>

SOURCE WaferGen Bio-systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. WaferGen Bio-systems Announces New Funding from Private Placement
2. WaferGen Launches SmartChip TE - A Novel Target Enrichment Solution for Next-Gen Sequencing (NGS) Aimed at Clinical Applications
3. WaferGen Bio-systems Launches MyDesign - Setting a New Standard in Flexibility with an Open Format High-Throughput qPCR Platform
4. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
5. Moleculin Reports Positive Data From Controlled Study of Novel Topical Psoriasis Treatment
6. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
7. Allied Healthcare Products Reports Loss On Sales Decline
8. TPI Reports Fiscal Year 2013 Financial Results
9. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Substantial Reductions of Triglycerides and Apoc-III in Patients with Familial Chylomicronemia
10. Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824
11. Isis Reports Follow-Up Data From ISIS-SMN Rx Phase 1 Study In Children With Spinal Muscular Atrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Today, the Partnership for Prescription Assistance ... research companies, unveiled a redesigned website ... and caregivers with faster, easier access to information ... assistance programs. Since its launch ... engage, educate and empower patients and caregivers to ...
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, ... stem cell-derived islet replacement therapy for the treatment of ... Dr. Eugene Brandon , Director of Strategic Relations ... annual summit showcases the latest in type 1 diabetes ... presentation are as follows: , , , ...
(Date:3/3/2015)... VIEW, Calif. , March 3, 2015 /PRNewswire/ ... enhanced drug discovery market, Frost & Sullivan recognizes ... & Sullivan Award for Technology Leadership. Neopeutics has ... clients a robust, cost-effective, and easily adaptable set ... agents that are catalogued as failing compounds in ...
Breaking Medicine Technology:Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 2ViaCyte to Present at JDRF TypeOneNation Research Summit 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 3Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 4Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 5
(Date:3/3/2015)... 03, 2015 Retrofit , the ... America’s leading corporations, today announces the appointment of its ... positions. CEO Mary Pigatti has recruited technology, ... employee engagement for the fast-growing company, which was recently ... for 2015. , “Retrofit is thrilled to announce ...
(Date:3/3/2015)... March 3, 2015, My Positive Perspective host was joined ... a unique one, not just because it was the first ... men who were both faced with monumental obstacles after being ... episode, Deierlein said to Collins, “I had the opportunity to ... very excited that you could join me on the set ...
(Date:3/3/2015)... 03, 2015 eMedEvents, a searchable ... medical education (CME) credit information, has officially been ... was initially launched in the United States (December ... kind in the field of healthcare conference technology ... this Denver, Colorado-based start-up company was successful as ...
(Date:3/3/2015)... FAYETTEVILLE, Ark. (PRWEB) March 03, 2015 ... , announced that Mr. William A. Breukelman has been ... has recently completed development of the first fully integrated ... is uniquely capable of analyzing the three-dimensional motion of ... and then comparing the analysis at 15,300 points to ...
(Date:3/3/2015)... York, NY (PRWEB) March 03, 2015 Ticket ... tickets for her 2015 tour. This well-known ticket ... added savings. , Arguably the biggest name in the music ... when Madonna performs on the “Rebel Heart Tour.” Madonna, fresh ... month will kick off her latest tour on August 29th ...
Breaking Medicine News(10 mins):Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 2Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 4Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:eMedEvents Launches Online Medical Conference, Speaker and CME Platform in India 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 2Health News:Cheap Madonna Tickets: Madonna Presale Tickets in Miami, New York, Brooklyn, Chicago, San Jose, Toronto, Edmonton & Vancouver Now Available at TicketDown.com 3
... more often in spinal fusions, but experts worry about costs ... A relatively new agent that stimulates the creation of new ... used in the United States, although costs and some complication ... new study reports. , The therapeutic agent, known as bone-morphogenic ...
... disease-linked factors don,t perform better than standard criteria, study ... biomarkers of cardiac risk, such as inflammation-linked C-reactive ... older, established factors such as smoking, obesity, high cholesterol ... newer blood-borne markers have been touted as a better ...
... decode the human genome and the information becomes publicly ... multiplying. Scientists at the National Institutes of Health were ... They evaluated responses to an online test among smokers ... variant associated with risk for lung cancer. The results, ...
... Study finds increased risk for postmenopausal women , ... blood pressure, elevated glucose and other components of metabolic ... cancer, a new study suggests. , Metabolic syndrome, also ... of such conditions as abdominal obesity, high blood glucose ...
... DALLAS, June 30 At the 8th Annual Spirit ... of North Texas (EFNT) recognized The Beryl Companies, the ... healthcare organizations, as the North Star 2009 Inductee. This ... example and show the importance of giving back to ...
... June 30 Every summer, the bloodsuckers send Canadians swatting ... good reason. , , More than just creatures ... and cause human flesh to swell and redden. An even ... , , While many Canadians warily use conventional ...
Cached Medicine News:Health News:Assessment of Bone Growth Stimulator Is Mixed 2Health News:Assessment of Bone Growth Stimulator Is Mixed 3Health News:Newer Blood Tests May Not Improve Heart Risk Assessment 2Health News:Newer Blood Tests May Not Improve Heart Risk Assessment 3Health News:Possible benefit from online genetic testing for lung cancer 2Health News:Metabolic Syndrome May Make Breast Cancer More Likely 2Health News:Beryl Receives Entrepreneurs Foundation of North Texas North Star Recognition 2
Cushing bayonet....
Straight, blunt tips....
Angled, pointed, with attached cable for Valleylab and other brands generators....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Medicine Products: